Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Z Orthop Unfall ; 151(3): 278-83, 2013 Jun.
Article in German | MEDLINE | ID: mdl-23794104

ABSTRACT

Autologous chondrocyte implantation (ACI) is an established two-step procedure for the treatment of full-thickness cartilage defects of the knee. Cartilage harvest from the affected knee joint represents the first step of this procedure and is essential for further in vitro expansion of autologous chondrocytes. Nevertheless, the cartilage biopsy process itself is underrepresented in the scientific literature and currently there is only a limited amount of data available addressing this process. Biopsy location as well as the technique itself and instruments used for cartilage collection are not well defined and only little standardisation can be found. The article describes the relevant aspects of the biopsy in the context of ACI with regard to the literature available. Follow-up studies to better define and standardise the cartilage biopsy process are thus required.


Subject(s)
Biopsy, Needle/methods , Cartilage, Articular/pathology , Cartilage, Articular/surgery , Chondrocytes/transplantation , Fractures, Cartilage/pathology , Fractures, Cartilage/surgery , Specimen Handling/methods , Cells, Cultured , Chondrocytes/pathology , Humans
2.
Knee Surg Sports Traumatol Arthrosc ; 21(3): 671-7, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22552618

ABSTRACT

PURPOSE: Autologous chondrocyte implantation (ACI) is a well-established treatment method for cartilage defects in knees. Age-related grouping was based on expression data of cartilage-specific markers. Specificities of ACI in the different populations were analysed. METHODS: Two hundred and sixty-seven patients undergoing ACI in the knee between 2006 and 2010 were included in this analysis. Cell characteristics and expression data of cartilage-specific surface markers as CD44, aggrecan and collagen type II were statistically analysed for age association. Epidemiological data of the defined groups were compared. Course of treatment was evaluated using MRI. RESULTS: A correlation analysis showed statistically significant associations between age and aggrecan or collagen type II expression in all patients <30 years. A cluster analysis could predict age-dependent expression of these markers separating groups with an average age of 18.1 ± 2.3 and 23.6 ± 4.2 years, respectively (p < 0.02). Discriminance analysis suggested the age border between adults and juveniles at about 20 years. There was no influence of age on cell characteristics or CD44 expression. In the 19 of 267 patients with an age ≤18 years, gender distribution was not different compared to adults, but patella was significantly more affected. Cartilage lesions were mainly caused by osteochondritis dissecans (OCD) and trauma. The Knee Osteoarthritis Scoring System in MRI reached 4.8 ± 2.3 points before, declining to 3.3 ± 2.3 points 6 and 12 months after the operation. CONCLUSIONS: Age-related expression of cartilage-specific markers allows definition of adolescents in cartilage regenerating surgery. Chondromalacia in these patients is mainly caused by OCD or trauma. LEVEL OF EVIDENCE: Case series, Level IV.


Subject(s)
Aggrecans/metabolism , Cartilage Diseases/therapy , Chondrocytes/transplantation , Collagen Type II/metabolism , Adolescent , Adult , Biomarkers/metabolism , Cartilage Diseases/metabolism , Child , Chondrocytes/metabolism , Female , Humans , Male , Middle Aged , Retrospective Studies , Transplantation, Autologous , Young Adult
3.
Osteoarthritis Cartilage ; 18(12): 1630-8, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20950698

ABSTRACT

OBJECTIVE: The aim of the current study was to identify molecular markers for articular cartilage (AC) that can be used as tools for the quality control of tissue engineered (TE) cartilage. DESIGN: A genome-wide expression analysis was performed using RNA isolated from articular and growth plate (GP) cartilage, both extracted from the knee joints of 6 weeks old minipigs. After confirming the specific expression for selected genes by RT-PCR, these were used as molecular markers for the quality control of TE cartilage. RESULTS: Albeit several known chondrocyte markers were expressed to a similar extent in articular and GP cartilage, our genome-wide expression analysis led us to identify genes being selectively expressed in either GP or articular chondrocytes. These findings led us to perform a RT-PCR expression analysis for the corresponding genes to demonstrate the absence of GP-specific markers in TE cartilage, while common or AC markers were expressed. CONCLUSIONS: Taken together, these results provide important novel insights into chondrocyte biology in general and AC in particular. In addition, it is reasonable to speculate, that some of the identified genes play distinct roles in the regulation of articular chondrocyte differentiation and/or function, thereby raising the possibility that they may serve as targets for non-operative therapies of osteoarthritis (OA).


Subject(s)
Cartilage, Articular/cytology , Chondrocytes/metabolism , Tissue Engineering/methods , Animals , Biomarkers , Cartilage, Articular/anatomy & histology , Cartilage, Articular/metabolism , Gene Expression , Gene Expression Profiling/methods , Genetic Markers , Genome-Wide Association Study/methods , Growth Plate/metabolism , Reverse Transcriptase Polymerase Chain Reaction/methods , Swine , Swine, Miniature
SELECTION OF CITATIONS
SEARCH DETAIL
...